Latest News
-
Wednesday - August 27, 2008
New Bayer CropScience active ingredient approved in Romania:
Thiencarbazone-methyl registered in first market
Annual sales potential of more than EUR 100 million for new corn herbicide
-
Thursday - August 21, 2008
Bayer and Onyx continue clinical investigation of sorafenib:
New Trial to Evaluate Nexavar® as Adjuvant Therapy in Liver Cancer
Enrollment initiated in international phase III study
-
Thursday - August 21, 2008
Further expansion of activities in China:
Bayer MaterialScience starts construction of a world-scale TDI plant in Shanghai
Annual capacity of 250,000 metric tons approved / Capacity can be increased to 300,000 metric tons per year / Start-up planned for 2010
-
Tuesday - August 19, 2008
Bayer HealthCare and Regeneron Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-related Macular Degeneration
Study patients, on average, received only two additional doses following a 12-week fixed dosing period
-
Tuesday - August 19, 2008
German premiere for polyurethane railway ties in the Leverkusen CHEMPARK
A material that is very much on track
Better dimensional and weather stability than wood, lighter than concrete
-
Tuesday - August 19, 2008
Bayer Schering Pharma to support USAID with contraceptives for family planning programs
Access to family planning for more than 8 million women in developing countries / 110 million cycles of oral contraceptives to be provided each year
-
Tuesday - August 12, 2008
Excellence in the Field of Communications Honored
Bayer’s Annual Report Receives International Praise
-
Friday - August 8, 2008
Light, high-endurance manhole covers made of polyurethane sandwich composite
Hermetically sealed on the road
-
Thursday - August 7, 2008
Bayer Schering Pharma strengthens its oncology R&D portfolio
Bayer acquires Preclinical Anti-cancer Program from Nycomed
Company assuming full development and commercialization rights
-
Tuesday - August 5, 2008
Bayer MaterialScience raises price for MDI
-
Tuesday - August 5, 2008
Makrolon® from Bayer MaterialScience for the German Embassy in Beijing:
“inForm” art installation – in peak condition for the Olympics
-
Thursday - July 31, 2008
Bayer appoints Greg Babe as new CEO for U.S. Organisation
Predecessor Dr. Attila Molnar to retire
-
Wednesday - July 30, 2008
Interim report for the second quarter of 2008
Bayer continues its success
Sales up 3.6 percent to EUR 8,511 million / EBITDA before special items increases by 5.0 percent to EUR 1,896 million / EBIT before special items improves by 5.3 percent to EUR 1,248 million / Full-year guidance for CropScience raised again / Group earnings forecast confirmed
-
Wednesday - July 30, 2008
Venous Blood Clot Prevention after Hip or Knee Replacement Surgery:
Bayer’s Novel Anticoagulant Rivaroxaban Submitted for Approval in the U.S.
Rivaroxaban is first oral anticoagulant to achieve superior efficacy over the twice-daily injection of enoxaparin while maintaining low rates of major bleeding / No evidence of safety issues attributable to rivaroxaban after long-term exposure
-
Tuesday - July 29, 2008
New markets
Bayer Technology Services and Xytel market microreaction technology
Flexible and high performance pilot plants for the oil & gas, chemical and pharmaceutical industries
-
Tuesday - July 29, 2008
New Internet site for thermoplastic polyurethanes:
Practical relevance online for every customer
-
Monday - July 28, 2008
Another milestone for cancer drug from Bayer and Onyx:
Nexavar Approved for Treatment of Liver Cancer in China
Nexavar is First Approved Systemic Therapy to Treat the Disease
-
Friday - July 25, 2008
Study Confirms that Levitra® on demand is Effective in Patients with ED after Nerve-sparing Prostatectomy
-
Friday - July 25, 2008
Venous Blood Clot Prevention after Elective Hip or Knee Replacement Surgery:
Bayer’s Novel Anticoagulant Rivaroxaban Recommended for Approval in the EU
Final approval from the European Commission expected within the next few months
-
Friday - July 25, 2008
Polycarbonate from Bayer MaterialScience covers Olympic events:
Makrolon® sheets in Chinese Olympic stadiums
Search
Publications
Stockholder's Newsletter
Annual Report 2007
Sustainable Development Report 2007
research – The Bayer Scientific Magazine
Publications Overview
Newsletter
Events
Download Center - Selection
